Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Open Access
- 19 July 2021
- Vol. 10 (7), 1821
- https://doi.org/10.3390/cells10071821
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Developing biomarkers for early detection and chemotherapeutic response prediction is crucial to improve the dismal prognosis of PDAC patients. However, molecular cancer signatures based on transcriptome analysis do not reflect intratumoral heterogeneity. To explore a more accurate stratification of PDAC phenotypes in an easily accessible matrix, plasma metabolome analysis using MxP® Global Profiling and MxP® Lipidomics was performed in 361 PDAC patients. We identified three metabolic PDAC subtypes associated with distinct complex lipid patterns. Subtype 1 was associated with reduced ceramide levels and a strong enrichment of triacylglycerols. Subtype 2 demonstrated increased abundance of ceramides, sphingomyelin and other complex sphingolipids, whereas subtype 3 showed decreased levels of sphingolipid metabolites in plasma. Pathway enrichment analysis revealed that sphingolipid-related pathways differ most among subtypes. Weighted correlation network analysis (WGCNA) implied PDAC subtypes differed in their metabolic programs. Interestingly, a reduced expression among related pathway genes in tumor tissue was associated with the lowest survival rate. However, our metabolic PDAC subtypes did not show any correlation to the described molecular PDAC subtypes. Our findings pave the way for further studies investigating sphingolipids metabolisms in PDAC.Keywords
Funding Information
- PePPP center of excellence (MV ESF/14-BM-A55-0045/16; ESF MVV-630-S-150-2012/132/133, FöFoLe, Reg. Nr.1028, Reg. Nr. 42/17, 2019.083.1)
- Deutsche Forschungsgemeinschaft (DFG RE3754/3-1 and SFB1321/1 (Project P14, 329628492))
- Bundesministerium für Bildung und Forschung (01EK1511A)
This publication has 40 references indexed in Scilit:
- Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic CancerBiomolecules, 2013
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLoS Medicine, 2012
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyNature Medicine, 2011
- Revitalizing membrane rafts: new tools and insightsNature Reviews Molecular Cell Biology, 2010
- A flexible R package for nonnegative matrix factorizationBMC Bioinformatics, 2010
- Lipid Rafts As a Membrane-Organizing PrincipleScience, 2010
- Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drugMolecular Cancer Therapeutics, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Characterization of acidic and neutral sphingomyelinase activities in crude extracts of HL-60 cellsChemistry and Physics of Lipids, 1999